Wed.May 21, 2025

article thumbnail

Roche strikes Orionis deal to develop ‘molecular glues’ for cancer

Bio Pharma Dive

The Swiss pharma has inked several collaborations in this field, suggesting it sees the approach as promising to rid the body of destructive proteins that are hard to target by other means.

article thumbnail

Viz.ai, Sanofi and Regeneron to link for COPD management

Pharmaceutical Technology

Viz.ai is set to enter into a multi-year collaboration with Sanofi and Regeneron for the management of COPD.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reproductive health startup raises $65M for infertility drugs

Bio Pharma Dive

Founded in 2021, ReproNovo has licensed rights to two drugs from Mereo BioPharma and ObsEva that it thinks could address fertility issues in men and women.

Drugs 144
article thumbnail

Navigating new EU regulations in the clinical supply chain

Pharmaceutical Technology

We learn how the EUs new Clinical Trial Regulation (CTR) and the CTIS platform are reshaping clinical trial approvals and the supply chain.

article thumbnail

How to Turn “Check-the-Box” Compliance Trainings Into Real Learning

Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group

Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable! Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. We'll explore innovative strategies to bring traditionally dry topics to life, making them resonate with learners and drive tangible change.

article thumbnail

UK trumpets £1bn investment plan from BioNTech

pharmaphorum

BioNTech has said it will commit up to 1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector

105
105
article thumbnail

ATS 2025: Real-world cohort study aligns with GSK depemokimab narrative

Pharmaceutical Technology

GSK will incorporate the findings into messaging that depemokimab patients will adhere to treatment better, ensuring better outcomes.

130
130

More Trending

article thumbnail

FDA to restrict Covid-19 booster doses to older adults

Pharmaceutical Technology

The US Food and Drug Administration (FDA) is set to restrict the Covid-19 booster doses to older adults and those at risk of severe illness.

Drugs 130
article thumbnail

The growth of radiotherapeutics: Addressing supply chain complexity

pharmaphorum

Players, current and emergent, should prepare for complexities in the supply chain as radiotherapeutics continues to rise.

64
article thumbnail

BioNTech to invest up to $1.34bn in UK R&D

Pharmaceutical Technology

BioNTech has entered a grant agreement with the UK government to expand its research and development (R&D) activities for medicines.

Medicine 130
article thumbnail

Buying Smart: The No-Nonsense Guide to Pharma Procurement

Drug Patent Watch

"The Prescription for Savings: How Smart Pharma Procurement Can Cut Costs Without Compromising Care As the pharmaceutical industry continues to evolve, one thing remains clear: the cost of prescription medications is a burden that's only getting heavier. But what if you could buy smart, not hard? A new guide from Drug Patent Watch reveals the secrets to savvy pharma procurement, helping healthcare leaders make informed decisions that put patients first.

Drugs 72
article thumbnail

Clinical Research White Paper – Enhancing Transparency & Efficiency Throughout the Trial Lifecycle

Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness

article thumbnail

ATS 2025: GSK strengthens argument for twice-annual depemokimab

Pharmaceutical Technology

Depemokimab reduces exacerbations regardless of baseline asthma control, suggesting uncontrolled symptoms are not necessary for response.

130
130
article thumbnail

Lead Gen in Pharma: Proven Strategies That Actually Convert

Pharma Marketing Network

Is your pharma brand generating leadsor just collecting contact forms? In a space as regulated and complex as pharmaceutical marketing, Lead Gen isnt just about volume. Its about conversion, compliance, and strategic targeting of healthcare professionals (HCPs), payers, and sometimes patients. While many life sciences companies continue to invest in email sign-ups and gated assets, far fewer have a consistent lead nurturing strategy that turns those leads into meaningful engagements or qualified

article thumbnail

WHO secures 20% funding increase amid US shortfall

Pharmaceutical Technology

Despite the boost to contributions, WHO has downsized its 2026-27 budget by over $1bn due to financial constraints.

130
130
article thumbnail

Big Moves for Bigger Impact: Elevating Agency Leadership to Enhance Client Success

Intouch Solutions

At EVERSANA INTOUCH, we are excited to announce leadership appointments that will directly benefit our pharmaceutical clients. These changes are designed to enhance our ability to deliver value-led advertising, market access, media, medical communications, and transformation solutions, ensuring that our clients receive unparalleled impact and strategic excellence.

article thumbnail

Can Your Organization Spot a Conflict Before It’s a Crisis?

Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk

In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?

article thumbnail

Beckley's psychedelic med inches forward in depression

pharmaphorum

UK psychedelic medicines developer Beckley Psytech has said its candidate for treatment-resistant depression has enhanced the effect of standard antidepressants in a phase 2 trial.The top-line data comes from the next stage (Part 2) of its ongoing trial looking at a single dose of Beckley's BPL-003 in 12 patients given on top of standard SSRI antidepressant therapy.

article thumbnail

LogiPharma Europe 2025: How Digitization Drives End to End Supply Chain Success

Pharmaceutical Commerce

Ruth Beadle, head, global supply chain, Sanofi, discusses how digital integration, advanced planning, and sustainability goals are transforming end-to-end supply chain operations to improve scale, speed, and environmental impact.

52
article thumbnail

How the IRA’s Part B Coinsurance Inflation Adjustments Can Raise Seniors’ Drug Costs

Drug Channels

The Inflation Reduction Act (IRA) is triggering increases in Medicare beneficiaries spending on their Part B drugs. Though CMS touts that the IRAs inflation-based coinsurance adjustments will "lower out-of-pocket costs," the results have been more complicated. Below, we update and expand on our previous analysis. We find that a growing number of Part B drugs now have inflation-adjusted coinsurance rates that are rising, not falling.

Drugs 52
article thumbnail

Challenging conventional wisdom on injectables, with Mehul Desai

pharmaphorum

Watch an insightful video interview with Mehul Desai as he challenges conventional wisdom on injectables and shares his unique perspective on the topic. Gain new insights and knowledge in this engaging conversation.

52
article thumbnail

White Paper - A Roadmap to AI Data Readiness in R&D Labs

Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.

article thumbnail

ICH E6(R3) Implementation Starts Now: Are You Ready?

Advarra

The release of ICH E6(R3) in January 2025 marks the most significant evolution in Good Clinical Practice (GCP) guidelines in over a decade. More than a revision, E6(R3) marks a shift from traditional practicesmaking participant safety and data reliability not just priorities, but design drivers, and introducing risk-based proportionality as a foundational approach.

Trials 52
article thumbnail

Top Email Marketing Platforms for Pharma: A 2025 Review of Compliant, High-Performing Tools

Pharma Marketing Network

Pharma email marketing platforms are no longer just digital toolstheyre the nerve center of healthcare communications in 2025. As more pharmaceutical brands race to connect with healthcare professionals (HCPs), payers, and patients in a compliant, data-driven way, the right platform makes all the difference. But how do you pick a platform that not only delivers strong ROI but also ensures HIPAA compliance, consent management, and CRM integration?

article thumbnail

FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research

Pharmaceutical Commerce

In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.

article thumbnail

Cancer News You Need: Changes to Social Security, Medicaid, State Paid Leave, & More

Triage Cancer

May 21, 2025 This blog covers the latest cancer news you need about new federal and state legislation, laws, and programs that may impact the community. This month we have information on Social Security, Medicaid, state paid leave, and more. National Updates What is Happening with Medicaid? Congress is proposing changes to Medicaid in their 2025 reconciliation bill.

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Moderna shares down after pulling Covid-flu combo vaccine application

Pharmaceutical Technology

After the FDA asked for more clinical data in May 2025, Moderna has decided to resubmit the BLA later this year.

article thumbnail

Pharma Pulse 5/21/25: The Road to Simpler and Better Clinical Trials; FDA Outlines Stricter Covid Vaccine Booster Standards for Healthy People

Pharmaceutical Commerce

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

article thumbnail

US imposes limits on COVID-19 boosters and new jabs

pharmaphorum

The FDA has introduced a stricter set of policies around COVID-19 vaccines, including requiring clinical trials for new shots in some cases.

article thumbnail

FDA panel backs Darzalex for early stage multiple myeloma

Bio Pharma Dive

Agency drug reviewers had questioned patient risk criteria and the efficacy endpoint used in a key trial supporting J&J's drug.

Trials 265
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Can pharma tariffs “Make America Manufacture Again”?

Pharmaceutical Technology

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

article thumbnail

The US Just Approved The First Blood Test For Alzheimer’s Disease

AuroBlog - Aurous Healthcare Clinical Trials blog

(Tek Image/Getty Images) The United States on Friday approved the first blood test for Alzheimer’s, a move that could help patients begin treatment earlier with newly approved drugs that slow the progression of the devastating neurological disease. The test, developed by Fujirebio Diagnostics, measures the ratio of two proteins in the blood.

Protein 143
article thumbnail

Ionis shares phase 3 results for olezarsen in moderate hypertriglyceridaemia

Pharma Times

The drug was recently approved in the US for familial chylomicronaemia syndrome

Drugs 120
article thumbnail

Medical centres in India emphase on protection of sensitive patient data as top priority

AuroBlog - Aurous Healthcare Clinical Trials blog

Medical centres in the country are emphasizing on protection of sensitive patient data as a top priority and a critical component of healthcare delivery. India’s regulatory framework, though complex, plays a vital role in maintaining these high standards.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model